Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.34 is in line with its 5-year average of 3.54, around the middle of its 5-year range (2.23–5.54).
As of the fiscal period ended Tuesday, June 30, 2026. 15.84% below its 12-month average of 3.97.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.34.
CURRENT RATIO
3.34
CURRENT RATIO AVG TTM
3.97
CURRENT RATIO AVG 3Y
4.20
CURRENT RATIO AVG 5Y
3.54
CURRENT RATIO AVG 10Y
6.42
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.84%
CURRENT VS 3Y AVG
-20.45%
CURRENT VS 5Y AVG
-5.67%
CURRENT VS 10Y AVG
-47.93%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.39
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
-1.41%
vs the sector median at left
Market Cap
$821.00M
Current Ratio
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
Market Cap
$785.44M
Current Ratio
4.26
TTM Avg
4.46
3Y Avg
3.96
5Y Avg
4.08
Market Cap
$770.68M
Current Ratio
13.37
TTM Avg
5.16
3Y Avg
5.50
5Y Avg
4.90
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $809.02M | 3.34 | 3.97 | 4.20 | 3.54 |
| Apnimed, Inc. (APMD)vs › | $807.90M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.59M | 8.18 | 10.05 | 10.24 | 9.72 |
| Jade Biosciences, Inc. (JBIO)vs › | $821.00M | 14.93 | 20.63 | 16.30 | 22.70 |
| Alumis Inc. (ALMS)vs › | $830.70M | 6.74 | 5.17 | 5.15 | 5.15 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $785.44M | 4.26 | 4.46 | 3.96 | 4.08 |
| AdaptHealth Corp. (AHCO)vs › | $784.35M | 1.12 | 1.18 | 1.21 | 1.17 |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | 8.88 | 7.47 | 6.98 | 6.98 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | 13.37 | 5.16 | 5.50 | 4.90 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $847.73M | 9.52 | 4.26 | 6.09 | 7.80 |
Current Ratio
3.34
Quick Ratio
3.15
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.34 |
| 2026-03-31 | 3.49 |
| 2025-12-31 | 4.31 |
| 2025-09-30 | 4.41 |
| 2025-06-30 | 4.30 |
| 2025-03-31 | 4.12 |
| 2024-12-31 | 4.58 |
| 2024-09-30 | 4.03 |
| 2024-06-30 | 4.21 |
| 2024-03-31 | 4.53 |
| 2023-12-31 | 4.88 |
| 2023-09-30 | 5.54 |
| 2023-06-30 | 2.63 |
| 2023-03-31 | 2.65 |
| 2022-12-31 | 2.34 |
| 2022-09-30 | 2.31 |
| 2022-06-30 | 2.34 |
| 2022-03-31 | 2.39 |
| 2021-12-31 | 2.53 |
| 2021-09-30 | 2.23 |
| 2021-06-30 | 3.23 |
| 2021-03-31 | 4.91 |
| 2020-12-31 | 6.87 |
| 2020-09-30 | 11.72 |
| 2020-06-30 | 6.29 |
| 2020-03-31 | 9.76 |
| 2019-12-31 | 11.36 |
| 2019-09-30 | 6.27 |
| 2019-06-30 | 7.79 |
| 2019-03-31 | 7.41 |
| 2018-12-31 | 10.02 |
| 2018-09-30 | 12.82 |
| 2018-06-30 | 14.20 |
| 2018-03-31 | 10.28 |
| 2017-12-31 | 8.39 |
| 2017-09-30 | 8.50 |
| 2017-06-30 | 8.37 |
| 2017-03-31 | 9.22 |
| 2016-12-31 | 10.62 |
| 2016-09-30 | 13.28 |
| 2016-06-30 | 10.70 |
| 2016-03-31 | 14.10 |
| 2015-12-31 | 14.53 |
| 2015-09-30 | 10.61 |
| 2015-06-30 | 25.95 |
| 2015-03-31 | 5.12 |
| 2014-12-31 | 20.03 |
| 2014-09-30 | 6.00 |
| 2014-06-30 | 4.47 |
| 2014-03-31 | 2.08 |
| 2013-12-31 | 2.44 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
